JP Morgan: Upgrades CK ASSET (01113) to "overweight" rating and raises target price to 52 Hong Kong dollars.
Although the performance of the Hong Kong real estate sector generally exceeded expectations, looking ahead to the second quarter, Morgan Stanley believes that this sector will also find it difficult to completely avoid the macro uncertainty brought about by the recent conflict in the Middle East.
JPMorgan Chase released a research report on CK ASSET (01113), maintaining a "buy" rating. Although the impact on the Hong Kong residential market has been slight since the outbreak of the war, the bank is inclined towards defensive stock selection due to its upcoming net cash position. The target price has been raised from 48.5 Hong Kong dollars to 52 Hong Kong dollars.
While the performance of Hong Kong property stocks has generally exceeded expectations, looking ahead to the second quarter, JPMorgan believes that this sector will also find it difficult to completely avoid the macro uncertainty brought about by recent Middle East conflicts. The main concern is the possibility of interest rate hikes, although the bank's current base case scenario still assumes that rates will remain unchanged until the first quarter of 2027.
At the same time, the bank has downgraded HENDERSON LAND (00012), which is sensitive to interest rates, and WHARF REIC (01997), whose earnings per share and dividend are uncertain, to a "neutral" rating. The former's target price has been reduced from 35 Hong Kong dollars to 30 Hong Kong dollars, while the latter's target price has been reduced from 29 Hong Kong dollars to 23 Hong Kong dollars.
The bank's top picks in the industry include developers such as SINO LAND (00083), SHK PPT (00016), and Cheung Kong; rental stocks such as SWIRE PROPERTIES (01972) and Hongkong Land. The bank also has a positive view on conglomerates such as CKH HOLDINGS (00001), as it benefits from rising oil prices.
Related Articles

MANY IDEA CLOUD (06696) will be suspended from trading starting from March 31st to await the release of insider information and the 2025 annual performance.

Daan Gene Co., Ltd.'s subsidiary obtained a medical device registration certificate.

CICC raises target price of BOC HONG KONG (02388) to HK$ 45.1, expected to achieve special shareholder returns in the first half of this year.
MANY IDEA CLOUD (06696) will be suspended from trading starting from March 31st to await the release of insider information and the 2025 annual performance.

Daan Gene Co., Ltd.'s subsidiary obtained a medical device registration certificate.

CICC raises target price of BOC HONG KONG (02388) to HK$ 45.1, expected to achieve special shareholder returns in the first half of this year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


